Herbal Science-brand supplements recalled

April 14, 2008

The U.S. Food and Drug Administration announced the recall of 12 Herbal Science-brand dietary supplements because they might present a health hazard.

The manufacturer, Herbal Science International Inc., also known as Jen-On Herbal Science International Inc. of City of Industry, Calif., said the supplements contain ephedra, aristolochic acid or human placenta -- all of which might cause varying hazards, such as dangerous effects on the heart and kidneys, the FDA said.

The supplements being recalled are:

-- Wu Yao Shun Qi San.

-- Qing Bi Tang (Nasal Cleanser).

-- Zhong Fong Huo Luo Wan (Stroke Revito Formula).

-- Xiao Qing Long Tang (Little Green Dragon).

-- Ding Chuan Tang.

-- Xiao Xu Ming Tang.

-- Feng Shi Zhi Tong Wan (Joint Relief).

-- Guo Min Bi Yan Wan.

-- Fang Feng Tong Sheng San.

-- Tou Tong San (Headache Formula).

-- Du Huo Ji Sheng Tang (Du Huo Joint Relief).

-- Seng Jong Tzu Tong Tan.

All 12 products, packed in white plastic bottles of 100 capsules, were sold nationwide.

Consumers can return the products to the place of purchase for a full refund. Consumers with questions can contact the company at 626-333-9998.

Copyright 2008 by United Press International

Related Stories

Recommended for you

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.